Cingulate Inc. Converts $1.65M Debt to Equity, Issuing Over 426K Shares
CING sits 37% above its 52-week low of $3.2.
Summary
Cingulate Inc. issued common stock valued at approximately $1.65 million to lenders in multiple transactions, converting a portion of its debt into equity and resulting in significant shareholder dilution.
Key Events · Financing and Capital Events · CING
-
Debt-to-Equity Conversion
Cingulate Inc. converted approximately $1.65 million in debt into common stock through a series of unregistered sales to lenders between November 21, 2025, and January 2, 2026.
-
Significant Share Dilution
A total of 426,853 shares of common stock were issued across six separate transactions, leading to a notable increase in the company's outstanding share count.
-
Balance Sheet Management
The conversions, exempt under Section 3(a)(9) of the Securities Act, indicate the company's strategy to reduce its debt obligations, which can be a critical step for small-cap companies managing financial health.
Analysis · CING · Life Sciences
Cingulate Inc. has engaged in a series of unregistered equity sales, converting approximately $1.65 million of debt into common stock. While this action reduces the company's outstanding debt, it results in significant dilution for existing shareholders, as over 426,000 new shares were issued. For a company of Cingulate's size, such a substantial conversion indicates a need to manage its balance sheet and potentially conserve cash, but at the cost of increasing the share count.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CING was trading at $4.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.6M. The 52-week trading range was $3.20 to $6.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.